Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 27,542Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 18BRISTOL MYERS SQUIBB

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

LENALIDOMIDE

US Patent Number : 8741929

Drug Substance Claim :

Drug Product Claim :

Application Number : 21880

Patent Use Code : U-1983

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-03-08

blank

02

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

LENALIDOMIDE

US Patent Number : 8741929

Drug Substance Claim :

Drug Product Claim :

Application Number : 21880

Patent Use Code : U-1983

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-03-08

blank

03

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

LENALIDOMIDE

US Patent Number : 8741929

Drug Substance Claim :

Drug Product Claim :

Application Number : 21880

Patent Use Code : U-1983

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-03-08

blank

04

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

LENALIDOMIDE

US Patent Number : 8741929

Drug Substance Claim :

Drug Product Claim :

Application Number : 21880

Patent Use Code : U-1983

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-03-08

blank

05

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

LENALIDOMIDE

US Patent Number : 8741929

Drug Substance Claim :

Drug Product Claim :

Application Number : 21880

Patent Use Code : U-1983

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-03-08

blank

06

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

LENALIDOMIDE

US Patent Number : 8741929

Drug Substance Claim :

Drug Product Claim :

Application Number : 21880

Patent Use Code : U-1983

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-03-08

blank

07

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

LENALIDOMIDE

US Patent Number : 7465800

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 21880

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-04-27

blank

08

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

LENALIDOMIDE

US Patent Number : 7855217

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 21880

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-11-24

blank

09

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

LENALIDOMIDE

US Patent Number : 7855217

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 21880

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-11-24

blank

10

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

LENALIDOMIDE

US Patent Number : 7855217

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 21880

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-11-24

blank